New Big Pharma Economies of Scale
How many patients are needed these days to make a drug a billion dollar blockbuster? Less than you think. What are the implications for pharmaceutical marketing?
Pharma Marketing News Vol. 10, No. 4: 23 FEBRUARY 2011
Welcome to Volume 10, Issue #4 (23 FEBRUARY 2011) of Pharma Marketing News.
Events I Witnessed, News You Made, & People We Met
The year 2010 was all about me. By 'me' I mean Pharmaguy, which is the Twitter handle and Facebook name of John Mack, Editor and Publisher of Pharma Marketing News. It's all about YOU too! This is where you can 'sign' the 2010 Pharma Marketing Yearbook and and document that you were part of it all.
Pharma’s Physician Bailout
The pharmaceutical industry has been very generous in making payments to physicians. Last year (2010), for example, a mere dozen pharmaceutical companies paid $760 million to physicians and other health care providers for consulting, speaking, research and expenses. On average, how much do you think that comes to for every physician in the U.S.?
Limiting Bias in Commercially Supported CME
Many critics of pharma-supported CME believe this support leads to bias. Between 9 May 2011 and 13 September 2011, readers of Pharma Marketing News were asked to answer a few short questions relating to potential bias in industry-supported CME programs and how to limit the need for industry funding of CME. The results are summarized in this article.
Evidence-Based Pharma Marketing: Using Science to Demonstrate Product Value
A conversation with Preeti Pinto, Principal at Preeti Pinto Consulting, LLC and former Executive Director & Head of Promotional Regulatory Affairs at AstraZeneca US, about the use of comparative effectiveness and health outcomes data in the support of drug promotion to physicians, payers, and consumers.
Pharma Marketing News Vol. 10, No. 2: JANUARY 19, 2011
Welcome to Volume 10, Issue #2 (JANUARY 19, 2011) of Pharma Marketing News.
Brits Beat FDA and PhRMA: Issue Social Media Guidance for Pharma
Prescription Medicines Code of Practice Authority Issues Social Media Guidance for Pharma. The Brits have won the race to issue social media guidance for the drug industry! In April, 2011, the Prescription Medicines Code of Practice Authority (PMCPA), which oversees the self-regulatory code of the Association of the British Pharmaceutical Industry (ABPI), published 'informal guidance' providing the drug industry advice on how to use online communications.
Pharma Marketing News Vol. 10, No. 8: 28 April 2011
Welcome to Volume 10, Issue #8 (28 APRIL 2011) of Pharma Marketing News.
GSK’s U.S. Sales Reps “Europeanized”: No Longer Rewarded for Ability to Push Prescriptions
An anonymous poster to CafePharma described what the
